Name: FDMT Balance Sheet - 4d Molecular Therapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

FDMT - 4d Molecular Therapeutics, Inc.

USD | NASDAQ | Healthcare

FDMT Balance Sheet - 4d Molecular Therapeutics Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q4 FY 18
Cash And Short Term Investments
Cash And Equivalents	72.5	60.2	48.6	77.2	133.5	149.3	187.5	189.1	275.6	249.1	275.7	236.3	78.6	52.4	108.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Cash And Short Term Investments
Cash And Equivalents	60.2	149.3	249.1	52.4	153.0	276.7	49.7	-
Restricted Cash	-	-	-	-	-	-	-	-
Short Term Investments	342.4	275.5	39.1	161.2	94.8	0.0	-	-
Cash And Short Term Investments	402.7	424.9	288.2	213.6	247.8	276.7	49.7	-
Receivables
Accounts Receivable	-	-	-	0.0	0.0	1.5	1.0	-
Current Assets
Inventory	-	-	-	-	-	-	-	-
Prepaid Expenses	10.5	10.1	8.4	7.0	8.5	4.4
Non-Current Assets
Property, Plant & Equipment Gross	36.1	36.1	32.1	30.0	19.7	8.9	7.7	-
Accumulated Depreciation	21.3	16.6	11.9	7.7
Current Liabilities
Accounts Payable	11.2	4.4	3.5	3.3	4.8	1.8	1.7	-
Short Term Debt	-	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	15.8	19.0	11.5	13.5	15.2
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-
Additional Paid In Capital	-	-	-	-	-	-
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	14.5	10.5	7.3	10.1	11.1	10.1	8.9	10.7	9.7	8.4	8.6	7.4	6.6	7.0	4.8	5.4	6.9	8.5
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	405.4	413.1	312.4	303.3	332.6	434.9	510.8	552.6	535.6	296.6	328.2	317.8	207.0	220.5	232.5	246.5

Non-Current Assets
Property, Plant & Equipment Gross	36.1	36.1	36.2	36.3	36.4	36.1	35.4	33.1	32.6	32.1	31.6	31.1	30.4	30.0	28.8	27.3	24.2	19.7	13.8	10.2	9.2	8.9	-	-	-	-	-
Accumulated Depreciation	22.5	21.3	20.1	18.8	17.6	16.6	15.5	14.3	13.1	11.9	10.8	9.8	8.8	7.7	6.7	6.2	5.7
Property,Plant & Equipment Net	13.6	14.9	16.2	17.5	18.7	19.5	19.9	18.8	19.5	20.1	20.7	21.3	21.6	22.3	22.1	21.1
Long Term Investments	66.7	111.4	67.2	123.8	137.0	80.6	48.8	35.7	62.9	11.0	0.0	0.0	1.4	4.9	11.1	20.5	48.4
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	17.4	18.1	18.9	19.6	20.4	21.1	21.8	10.7	11.1	11.5	12.0	12.4	12.7	13.1	13.5	13.8
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	9.9	9.2	9.4	9.4	7.0	4.3	2.9	2.3	0.8	0.7	0.7	1.1	1.3	1.1	1.1	1.0	0.9
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	512.9	566.7	424.0	473.6	515.7	560.4	604.0	620.1	629.9	339.9	361.6	352.5	244.0	261.8	280.2	302.9	324.9

Current Liabilities
Accounts Payable	14.7	11.2	6.9	8.7	4.2	4.4	2.9	3.4	4.2	3.5	4.7	3.5	2.4	3.3	1.5	3.3	2.7	4.8	3.7	2.0	1.3	1.8	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	0.4	0.4	0.4	1.1	0.9	0.3	0.0	0.0	0.0	0.3	0.1	0.6	0.8	0.9	2.2	2.3	2.1
Operating Lease Liabilities Current	5.5	5.6	5.7	5.7	5.7	5.6	5.1	3.2	3.2	3.1	3.1	3.1	2.7	2.7	2.6	2.6
Accrued Expenses	22.9	26.9	24.2	19.2	16.2	18.9	21.4	12.8	9.0	12.0	10.2	6.6	5.4	8.9	7.2	6.2	5.3	7.7
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	43.4	44.0	37.1	34.7	26.9	29.1	29.5	19.4	16.4	19.0	18.2	13.7	11.3	15.7	13.6

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-
Additional Paid In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	(785.1)	(716.3)	(735.7)	(678.8)	(624.2)	(576.2)	(526.5)	(482.7)	(447.7)	(415.3)	(383.0)	(372.8)	(343.2)	(314.5)	(287.1)	(261.4)	(233.3)
Accumulated Other Comprehensive Income	(0.2)	0.7	0.7	0.3	0.3	0.2	1.1	(0.3)	(0.1)	0.0	0.5	0.3	(0.3)	(1.2)	(1.9)	(1.8)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	451.8	505.7	369.0	420.9	469.7	510.6	552.9	588.3	600.6	307.8	329.9	325.1	218.6	231.3	251.4	272.5	296.1
Total Equity	451.8	505.7	369.0	420.9	469.7	510.6	552.9	588.3	600.6	307.8	329.9	325.1	218.6	231.3	251.4	272.5	296.1	319.1

Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Working Capital	362.0	369.1	275.3	268.6	305.7	405.8	481.3	533.2	519.2	277.6	310.1	304.0	195.8	204.8	218.9	232.2	231.0	239.9
Book Value	451.8	505.7	369.0	420.9	469.7	510.6	552.9	588.3	600.6	307.8	329.9	325.1	218.6	231.3	251.4	272.5	296.1	319.1
Tangible Book Value	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-